Anna Martínez-Cardús

10PUBLICATIONS
60CO-AUTHORS
Molecular targetsPredictive and prognostic markersChiropracticPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 11, 2026
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.

Daniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez

|Feb 15, 2022
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.

Eudald Felip, Lucía Gutiérrez-Chamorro, Maica Gómez

|Oct 27, 2020
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.

Anna Esteve-Codina, Francesc Alameda, Cristina Carrato

|Jul 03, 2020
Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713.

Marc Castellví, Eudald Felip, Ifeanyi Jude Ezeonwumelu

|Jun 05, 2020
Publisher Correction: MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer.

Trine B Mattesen, Mads H Rasmussen, Juan Sandoval

|Apr 26, 2020
MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer.

Trine B Mattesen, Mads H Rasmussen, Juan Sandoval

Pageof 2

Frequent Collaborators

4 joint publications

Manel Esteller

3 joint publications

Eudald Felip

2 joint publications

Margarita Romeo

2 joint publications

Josephine Gladov